window.protocolData = window.protocolData || {};
window.protocolData.gist = {
  "neoadjuvant": {
    "Imatinib-Neo": {
      "name": "Imatinib (KIT/PDGFRA inhibitor)",
      "cycles": 6,
      "drugs": [
        {
          "name": "Imatinib",
          "dose": 400,
          "unit": "mg",
          "schedule": "PO once daily"
        }
      ]
    },
    "Avapritinib-Neo": {
      "name": "Avapritinib (PDGFRA D842V+) (KIT/PDGFRA inhibitor)",
      "cycles": 6,
      "drugs": [
        {
          "name": "Avapritinib",
          "dose": 300,
          "unit": "mg",
          "schedule": "PO once daily"
        }
      ]
    }
  },
  "adjuvant": {
    "Imatinib-Adj": {
      "name": "Imatinib (ACOSOG Z9001/SSG XVIII) (KIT/PDGFRA inhibitor)",
      "cycles": 36,
      "drugs": [
        {
          "name": "Imatinib",
          "dose": 400,
          "unit": "mg",
          "schedule": "PO once daily x 3 years"
        }
      ]
    }
  },
  "metastatic": {
    "Imatinib-400": {
      "name": "Imatinib 400mg (B2222) (KIT/PDGFRA inhibitor)",
      "drugs": [
        {
          "name": "Imatinib",
          "dose": 400,
          "unit": "mg",
          "schedule": "PO once daily until progression"
        }
      ]
    },
    "Imatinib-800-Exon9": {
      "name": "Imatinib 800mg (KIT exon 9 mutation) (KIT/PDGFRA inhibitor)",
      "drugs": [
        {
          "name": "Imatinib",
          "dose": 400,
          "unit": "mg",
          "schedule": "PO twice daily (800mg total daily dose) until progression"
        }
      ]
    },
    "Avapritinib-PDGFRA": {
      "name": "Avapritinib (NAVIGATOR) (PDGFRA D842V+) (KIT/PDGFRA inhibitor)",
      "drugs": [
        {
          "name": "Avapritinib",
          "dose": 300,
          "unit": "mg",
          "schedule": "PO once daily until progression"
        }
      ]
    },
    "Sunitinib-2L": {
      "name": "Sunitinib (A6181004) (multi-kinase inhibitor)",
      "drugs": [
        {
          "name": "Sunitinib",
          "dose": 50,
          "unit": "mg",
          "schedule": "PO once daily D1-28, every 42 days"
        }
      ]
    },
    "Regorafenib-3L": {
      "name": "Regorafenib (GRID) (multi-kinase inhibitor)",
      "drugs": [
        {
          "name": "Regorafenib",
          "dose": 160,
          "unit": "mg",
          "schedule": "PO once daily D1-21, every 28 days"
        }
      ]
    },
    "Ripretinib-4L": {
      "name": "Ripretinib (INVICTUS) (KIT/PDGFRA inhibitor)",
      "drugs": [
        {
          "name": "Ripretinib",
          "dose": 150,
          "unit": "mg",
          "schedule": "PO once daily until progression"
        }
      ]
    },
    "Larotrectinib-NTRK": {
      "name": "Larotrectinib (NAVIGATE) (NTRK fusion+) (TRK inhibitor)",
      "drugs": [
        {
          "name": "Larotrectinib",
          "dose": 100,
          "unit": "mg",
          "schedule": "PO twice daily until progression"
        }
      ]
    },
    "Entrectinib-NTRK": {
      "name": "Entrectinib (STARTRK-2) (NTRK fusion+) (TRK inhibitor)",
      "drugs": [
        {
          "name": "Entrectinib",
          "dose": 600,
          "unit": "mg",
          "schedule": "PO once daily until progression"
        }
      ]
    },
    "Repotrectinib-NTRK": {
      "name": "Repotrectinib (TRIDENT-1) (NTRK fusion+) (TRK inhibitor)",
      "drugs": [
        {
          "name": "Repotrectinib",
          "dose": 160,
          "unit": "mg",
          "schedule": "PO once daily x 14 days, then 160mg PO twice daily until progression"
        }
      ]
    },
    "Dabrafenib-Trametinib-BRAF": {
      "name": "Dabrafenib + Trametinib (BRAF V600E+) (BRAF + MEK inhibitors)",
      "drugs": [
        {
          "name": "Dabrafenib",
          "dose": 150,
          "unit": "mg",
          "schedule": "PO twice daily until progression"
        },
        {
          "name": "Trametinib",
          "dose": 2,
          "unit": "mg",
          "schedule": "PO once daily until progression"
        }
      ]
    }
  }
};
